Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer

The recruitment status of this study is unknown because the information has not been verified recently.

Verified August 2009 by Institut Gustave Roussy.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Institut Gustave Roussy

ClinicalTrials.gov Identifier:

NCT00949039

First received: July 7, 2009

Last updated: August 21, 2009

Last verified: August 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	February 2011
Estimated Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)